These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 12125711)
41. 13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia. Milazzo L; Riva A; Sangaletti O; Piazza M; Antinori S; Moroni M J Acquir Immune Defic Syndr; 2004 Apr; 35(4):429-32. PubMed ID: 15097162 [No Abstract] [Full Text] [Related]
42. HIV and Cardiovascular Disease. Bozzette SA Clin Infect Dis; 2011 Jul; 53(1):92-3. PubMed ID: 21653309 [No Abstract] [Full Text] [Related]
43. Lack of mitochondrial toxicity in CEM cells treated with carbovir. Parker WB; Shaddix SC; Vince R; Bennett LL Antiviral Res; 1997 May; 34(3):131-6. PubMed ID: 9191020 [TBL] [Abstract][Full Text] [Related]
44. Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled? Fichtenbaum CJ; Mallon P AIDS; 2023 Mar; 37(3):541-543. PubMed ID: 36695364 [No Abstract] [Full Text] [Related]
45. Anaerobic threshold and random venous lactate levels among HIV-positive patients on antiretroviral therapy. Tesiorowski AM; Harris M; Chan KJ; Thompson CR; Montaner JS J Acquir Immune Defic Syndr; 2002 Oct; 31(2):250-1. PubMed ID: 12394805 [No Abstract] [Full Text] [Related]
46. Lymphocyte activity and protein synthesis. MacAllan DC Clin Sci (Lond); 2001 Dec; 101(6):591-2. PubMed ID: 11724644 [No Abstract] [Full Text] [Related]
47. Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients. Simmons JD; Gillespie MN Coron Artery Dis; 2015 Jun; 26(4):286-288. PubMed ID: 25909176 [No Abstract] [Full Text] [Related]
48. Cell-free DNA as a promising marker for risk stratification of pulmonary embolism. Neto-Neves EM Crit Care; 2013 Nov; 17(6):464. PubMed ID: 24245555 [No Abstract] [Full Text] [Related]
49. [Diagnosis on adverse drug reactions]. Ueda S Nihon Rinsho; 2012 Aug; 70 Suppl 6():25-8. PubMed ID: 23156482 [No Abstract] [Full Text] [Related]
50. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Claessens YE; Chiche JD; Mira JP; Cariou A Crit Care; 2003 Jun; 7(3):226-32. PubMed ID: 12793872 [TBL] [Abstract][Full Text] [Related]
51. Mitochondrial dysfunction in HIV infection: an overview of pathogenesis. Rustin P J HIV Ther; 2001 Mar; 6(1):4-12. PubMed ID: 11501198 [No Abstract] [Full Text] [Related]
52. Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity? de Mendoza C; Sanchez-Conde M; Ribera E; Domingo P; Soriano V AIDS Rev; 2004; 6(3):169-80. PubMed ID: 15595434 [TBL] [Abstract][Full Text] [Related]
53. Mitochondrial DNA and nucleoside toxicity. Casademont J; Miró O; Cardellach F N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125711 [No Abstract] [Full Text] [Related]
54. Mitochondrial DNA and nucleoside toxicity. Chariot P; Bourokba N; Brivet F N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12124414 [No Abstract] [Full Text] [Related]
55. Mitochondrial DNA and nucleoside toxicity. Rastegar DA N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125710 [No Abstract] [Full Text] [Related]
56. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. Côté HC; Brumme ZL; Craib KJ; Alexander CS; Wynhoven B; Ting L; Wong H; Harris M; Harrigan PR; O'Shaughnessy MV; Montaner JS N Engl J Med; 2002 Mar; 346(11):811-20. PubMed ID: 11893792 [TBL] [Abstract][Full Text] [Related]